Integral Molecular lands $8M NIAID contract to battle emerging viruses
Integral Molecular, a company that develops vaccines and therapeutics, announced a five-year $8 million contract from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID).The funding will be used to…
Continue Reading